Home/Filings/4/0001593968-22-001746
4//SEC Filing

Vanhove Geertrui 4

Accession 0001593968-22-001746

CIK 0001824893other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 6:53 PM ET

Size

4.9 KB

Accession

0001593968-22-001746

Insider Transaction Report

Form 4
Period: 2022-12-15
Vanhove Geertrui
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-12-15$0.41/sh+9,578$3,92732,412 total
Footnotes (1)
  • [F1]These shares were acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

Surrozen, Inc./DE

CIK 0001824893

Entity typeother

Related Parties

1
  • filerCIK 0001771994

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 6:53 PM ET
Size
4.9 KB